
Mexico Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Ind
Description
Mexico Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032
The Mexico point-of-care glucose testing market is positioned to grow in the coming years owing to the growing occurrence of diabetic issues, in addition to the increasing implementation of cutting-edge innovations into diabetic person treatment. The marketplace is fractional by the item kind, application, and finish individual. The marketplace gets on the verge of advancement due to the advancements in innovation making it more accurate and effective. Significant stakeholders out there consist of Diagnostic and Drug business, Clinical gadget firms, as well as Bio-tech firms, to name a few.
The Mexico point-of-care glucose testing market is driven by various aspects, such as the rising frequency of diabetic issues, the climbing importance connected to the early detection and therapy of diabetes, the accessibility of compensation for point-of-care screening items, the increased infiltration of technically progressed products, and the increasing variety of diabetes-related study programmes. Additionally, government-backed initiatives targeted at raising recognition and also motivating safety nets are promoting the adoption of point-of-care glucose testing products. However, numerous elements such as the high price of glucose testing products, the lack of strong medical care infrastructure, as well as the incorrect application of medical methods as well as criteria might impede the growth of this market.
The market uses a number of profitable possibilities, such as the intro of innovative items, the enhancing consolidation of preventive healthcare actions, and also the schedule of repayment for point-of-care testing items. The market for point-of-care glucose screening products is anticipated to grow in the coming years due to the boosting understanding of diabetes and also its associated risks among individuals. Additionally, the intro of cost-efficient products out there, the partnership between diabetes mellitus care stakeholders, and the development of enhanced point-of-care testing items are expected to propel the market growth. Additionally, the introduction of ARTiStripTM, a non-invasive point-of-care sugar screening tool and also the arising pattern of electronic health are expected to use extra development possibilities.
The Mexico point-of-care glucose testing market uses several growth opportunities, such as the introduction of technically progressed products, the partnership between diabetes treatment stakeholders, the inclusion of point-of-care glucose examination in routine applications, and also the boosting setup of point-of-care sugar screening items in the homecare settings. Furthermore, with the enhancing federal government treatments as well as initiatives to raise recognition concerning diabetes mellitus, the marketplace is expected to witness additional growth in the coming years.
The high price of the tools and the lack of well-developed health care framework in some areas are limiting the growth of the market. Furthermore, the Mexico point-of-care glucose testing market is managed by the nationwide authorities, along with by the national federal government, which regulates using products for clinical diagnostics. Additionally, precise implementation of medical procedures as well as standards is very important for the reliable functioning of the Mexico point-of-care glucose testing market. The Mexico point-of-care glucose testing market is fractional by item kind, application, and end individual. Based on item type, the marketplace is divided into lancing gadgets and strips and blood-glucose meters. On the basis of application, the market is classified into kind 1 diabetic issues and kind 2 diabetes mellitus. Additionally, the point-of-care glucose testing market is segmented by end individual into healthcare facilities as well as centers, house care settings, as well as others.
Mexico is extremely impacted by diabetic issues as well as its connected issues. The increasing prevalence of diabetic issues, in addition to its difficult-to-manage problems, has actually required the requirement for effective therapy and also diagnosis. Because of this, the Mexico point-of-care glucose testing market is anticipated to witness substantial growth in the coming years. Moreover, the rising awareness about diabetes mellitus as well as its associated risks, in addition to the growing infiltration of highly advanced items, are anticipated to drive the market growth. The Mexico point-of-care glucose testing market is anticipated to witness considerable growth during the projection period, owing to the raising prevalence of diabetes mellitus as well as the availability of innovative items out there. Moreover, the rising number of diabetes-related research study programs and also government-backed campaigns to raise recognition for diabetics issues are expected to boost the market development.
This concierge's five pressure analysis supplies an empirical view of the Mexico point-of-care glucose testing market as well as its good looks. The evaluation includes purchasers' power, replaces' schedule, obstacles to access and also departure, as well as distributors and rivals. The customers' power is low given that there are several gamers on the market, each with considerable market shares. As a result, customers can switch their providers. In addition, purchasers get eye-catching discount rates and services from the suppliers owing to the competitors on the market.
Key Benefits For Stakeholders
Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
Analyze the key strategies adopted by major market players in Mexico point-of-care glucose testing market.
Assess and rank the top factors that are expected to affect the growth of Mexico point-of-care glucose testing market.
Top Player positioning provides a clear understanding of the present position of market players.
Detailed analysis of the Mexico point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
Identify key investment pockets for various offerings in the market.
Product Benchmarking / Product specification and applications
Upcoming/New Entrant by Regions
New Product Development/ Product Matrix of Key Players
Patient/epidemiology data at country, region, global level
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis
Key Market Segments
By Product Type
Lancing Devices and Strips
Blood-Glucose Meter
Type
Lifescan OneTouch Ultra and Lifescan OneTouch Verio
Accu-Chek Aviva Plus and Accuchek
Freestyle Lite and Freestyle Precission Neo
Contour Next
Others
By Application
Type-1 Diabetes
Type-2 Diabetes
By End User
Hospitals and Clinics
Home Care Settings
Others
Key Market Players
Roche
Abbott
Bayer
Siemens Healthineers
Sysmex
Nova Biomedical
LipoScience
Acon Laboratories
Trinity Biotech
Hycel Medicals
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
80 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits to the Stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Impacting Factors
- 3.2.2. Top Investment Pockets
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market Size and Forecast, By Product Type
- 4.2. Lancing Devices and Strips
- 4.3. Blood-Glucose Meter
- CHAPTER 5: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market Size and Forecast, By Application
- 5.2. Type-1 Diabetes
- 5.3. Type-2 Diabetes
- CHAPTER 6: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market Size and Forecast, By End User
- 6.2. Hospitals and Clinics
- 6.3. Home Care Settings
- 6.4. Others
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top player positioning, 2022
- CHAPTER 8: COMPANY PROFILES
- 8.1. Roche
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
- 8.2. Abbott
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
- 8.3. Bayer
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
- 8.4. Siemens Healthineers
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
- 8.5. Sysmex
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
- 8.6. Nova Biomedical
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
- 8.7. LipoScience
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
- 8.8. Acon Laboratories
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
- 8.9. Trinity Biotech
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
- 8.10. Hycel Medicals
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 02. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 03. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 04. ROCHE: KEY EXECUTIVES
- TABLE 05. ROCHE: COMPANY SNAPSHOT
- TABLE 06. ROCHE: OPERATING SEGMENTS
- TABLE 07. ROCHE: PRODUCT PORTFOLIO
- TABLE 08. ROCHE: KEY STRATERGIES
- TABLE 09. ABBOTT: KEY EXECUTIVES
- TABLE 10. ABBOTT: COMPANY SNAPSHOT
- TABLE 11. ABBOTT: OPERATING SEGMENTS
- TABLE 12. ABBOTT: PRODUCT PORTFOLIO
- TABLE 13. ABBOTT: KEY STRATERGIES
- TABLE 14. BAYER: KEY EXECUTIVES
- TABLE 15. BAYER: COMPANY SNAPSHOT
- TABLE 16. BAYER: OPERATING SEGMENTS
- TABLE 17. BAYER: PRODUCT PORTFOLIO
- TABLE 18. BAYER: KEY STRATERGIES
- TABLE 19. SIEMENS HEALTHINEERS: KEY EXECUTIVES
- TABLE 20. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
- TABLE 21. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
- TABLE 22. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
- TABLE 23. SIEMENS HEALTHINEERS: KEY STRATERGIES
- TABLE 24. SYSMEX: KEY EXECUTIVES
- TABLE 25. SYSMEX: COMPANY SNAPSHOT
- TABLE 26. SYSMEX: OPERATING SEGMENTS
- TABLE 27. SYSMEX: PRODUCT PORTFOLIO
- TABLE 28. SYSMEX: KEY STRATERGIES
- TABLE 29. NOVA BIOMEDICAL: KEY EXECUTIVES
- TABLE 30. NOVA BIOMEDICAL: COMPANY SNAPSHOT
- TABLE 31. NOVA BIOMEDICAL: OPERATING SEGMENTS
- TABLE 32. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
- TABLE 33. NOVA BIOMEDICAL: KEY STRATERGIES
- TABLE 34. LIPOSCIENCE: KEY EXECUTIVES
- TABLE 35. LIPOSCIENCE: COMPANY SNAPSHOT
- TABLE 36. LIPOSCIENCE: OPERATING SEGMENTS
- TABLE 37. LIPOSCIENCE: PRODUCT PORTFOLIO
- TABLE 38. LIPOSCIENCE: KEY STRATERGIES
- TABLE 39. ACON LABORATORIES: KEY EXECUTIVES
- TABLE 40. ACON LABORATORIES: COMPANY SNAPSHOT
- TABLE 41. ACON LABORATORIES: OPERATING SEGMENTS
- TABLE 42. ACON LABORATORIES: PRODUCT PORTFOLIO
- TABLE 43. ACON LABORATORIES: KEY STRATERGIES
- TABLE 44. TRINITY BIOTECH: KEY EXECUTIVES
- TABLE 45. TRINITY BIOTECH: COMPANY SNAPSHOT
- TABLE 46. TRINITY BIOTECH: OPERATING SEGMENTS
- TABLE 47. TRINITY BIOTECH: PRODUCT PORTFOLIO
- TABLE 48. TRINITY BIOTECH: KEY STRATERGIES
- TABLE 49. HYCEL MEDICALS: KEY EXECUTIVES
- TABLE 50. HYCEL MEDICALS: COMPANY SNAPSHOT
- TABLE 51. HYCEL MEDICALS: OPERATING SEGMENTS
- TABLE 52. HYCEL MEDICALS: PRODUCT PORTFOLIO
- TABLE 53. HYCEL MEDICALS: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
- FIGURE 03. TOP INVESTMENT POCKETS IN MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
- FIGURE 04. PORTER FIVE-1
- FIGURE 05. PORTER FIVE-2
- FIGURE 06. PORTER FIVE-3
- FIGURE 07. PORTER FIVE-4
- FIGURE 08. PORTER FIVE-5
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET
- FIGURE 10. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
- FIGURE 11. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
- FIGURE 12. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
- FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 17. COMPETITIVE DASHBOARD
- FIGURE 18. COMPETITIVE HEATMAP: MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET
- FIGURE 19. TOP PLAYER POSITIONING, 2022
- FIGURE 20. ROCHE: NET SALES, 2020-2022* ($MILLION)
- FIGURE 21. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 22. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 23. ABBOTT: NET SALES, 2020-2022* ($MILLION)
- FIGURE 24. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 25. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 26. BAYER: NET SALES, 2020-2022* ($MILLION)
- FIGURE 27. BAYER: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 28. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 29. SIEMENS HEALTHINEERS: NET SALES, 2020-2022* ($MILLION)
- FIGURE 30. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 31. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 32. SYSMEX: NET SALES, 2020-2022* ($MILLION)
- FIGURE 33. SYSMEX: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 34. SYSMEX: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 35. NOVA BIOMEDICAL: NET SALES, 2020-2022* ($MILLION)
- FIGURE 36. NOVA BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 37. NOVA BIOMEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 38. LIPOSCIENCE: NET SALES, 2020-2022* ($MILLION)
- FIGURE 39. LIPOSCIENCE: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 40. LIPOSCIENCE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 41. ACON LABORATORIES: NET SALES, 2020-2022* ($MILLION)
- FIGURE 42. ACON LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 43. ACON LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 44. TRINITY BIOTECH: NET SALES, 2020-2022* ($MILLION)
- FIGURE 45. TRINITY BIOTECH: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 46. TRINITY BIOTECH: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- FIGURE 47. HYCEL MEDICALS: NET SALES, 2020-2022* ($MILLION)
- FIGURE 48. HYCEL MEDICALS: REVENUE SHARE, BY SEGMENT, 2022 (%)
- FIGURE 49. HYCEL MEDICALS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.